Effectiveness of implantable cardioverter defibrillator as primary prevention in hypertrophic cardiomyopathy: One year follow-up study

被引:0
|
作者
Fadaam, Hasan Ahmed [1 ]
Al-Musawi, Ali Abdul-Amir [1 ]
Al-Iqabby, Kasim Abbas Ismail [1 ]
机构
[1] Ibn Al Bitar Specialized Ctr Cardiac Surg, Baghdad, Iraq
来源
REVISTA LATINOAMERICANA DE HIPERTENSION | 2023年 / 18卷 / 01期
关键词
Hypertrophic Cardiomyopathy; Implantable cardioverter defibrillator; Sudden cardiac death; SUDDEN CARDIAC DEATH; VENTRICULAR-TACHYCARDIA; EFFICACY; RISK;
D O I
10.5281/zenodo.7778653
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Hereditary hypertrophic cardiomyopathy (HCM) is characterized by unexplained left ventricular hypertrophy and varied clinical manifestations. The worst outcome of this disorder, ventricular fibrillation, is sudden cardiac death (SCD), hence the only effective treatment is an implanted cardioverter-defibrillator (ICD). Objective: ICD as a significant preventative technique for hypertrophic cardiomyopathy to avoid sudden cardiac death, study ICD shock risk factors and predictors, ICD suitable shock and their predictions. Method: In an observational, prospective cohort trial, 33 consecutive men and women got ICD treatment to prevent HCM. Patients aged 35-64 were examined at Ibn Al Bitar Specialist Center for Heart Surgery in 2017 for one-year follow-up. At ICD programming visits, all patients had transthoracic echocardiography and were compared to a previous echo exam. Results: 33 patients completed the investigation, with a mean age of 46.5 +/- 7.1, lowest age 35, highest age 64, and 1.2:1 male-to-female ratio. Non-sustained VT on Holter, family history of sudden cardiac death, repeated syncope episodes, and left ventricular wall thickness <30mm increased ICD implantation. 24.2% had two risks, 12.1% three, and 63.6% one. 36.4% positive ICD treatment, all ATP, and all shocks were tested. 27.3% had excellent ICD shock. Women experienced more ICD shocks than men regardless of age. SCD and syncope in the family elevated ICD shock rates. ICD shock risk was higher in women, repeated syncope, and sudden cardiac death families. ICD treatment helps younger patients, those with a positive family history of sudden cardiac death, non-sustained VT, and larger left ventricular outflow tract diameters. Conclusion: ICD shock is more frequent in women with a family history of SCD, syncope, and numerous risk factors. HCM patients with one risk factor may get an ICD as primary prevention. Several risk factors increase ICD shock risk. Inappropriate shock is linked to advanced age and decreased left ventricular outflow tract.
引用
收藏
页码:20 / 25
页数:6
相关论文
共 50 条
  • [41] Long-Term Benefit of Primary Prevention With an Implantable Cardioverter-Defibrillator An Extended 8-Year Follow-Up Study of the Multicenter Automatic Defibrillator Implantation Trial II
    Goldenberg, Ilan
    Gillespie, John
    Moss, Arthur J.
    Hall, W. Jackson
    Klein, Helmut
    McNitt, Scott
    Brown, Mary W.
    Cygankiewicz, Iwona
    Zareba, Wojciech
    CIRCULATION, 2010, 122 (13) : 1265 - 1271
  • [42] Implantable cardioverter-defibrillator in pregnant women with hypertrophic cardiomyopathy
    Cordeiro de Paula, Leonardo Jorge
    Ribeiro, Henrique Barbosa
    de Oliveira Junior, Roberto Marcio
    da Silva, Katia Regina
    REVISTA BRASILEIRA DE CIRURGIA CARDIOVASCULAR, 2010, 25 (03): : 406 - 409
  • [43] Follow-up of implantable cardioverter-defibrillator therapy: comparison of coronary artery disease and dilated cardiomyopathy
    M. P. Verhagen
    N. van Boven
    J. H. Ruiter
    G-J. P. Kimman
    G. J. Tahapary
    V. A. Umans
    Netherlands Heart Journal, 2014, 22 : 431 - 437
  • [44] Follow-up of implantable cardioverter-defibrillator therapy: comparison of coronary artery disease and dilated cardiomyopathy
    Verhagen, M. P.
    van Boven, N.
    Ruiter, J. H.
    Kimman, G-J. P.
    Tahapary, G. J.
    Umans, V. A.
    NETHERLANDS HEART JOURNAL, 2014, 22 (10) : 431 - 437
  • [45] COMPLICATIONS OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR THERAPY - FOLLOW-UP OF 241 PATIENTS
    GRIMM, W
    FLORES, BF
    MARCHLINSKI, FE
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1993, 16 (01): : 218 - 222
  • [46] Role of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome: A long-term follow-up
    Moennig, Gerold
    Koebe, Julia
    Loeher, Andreas
    Wasmer, Kristina
    Milberg, Peter
    Zellerhoff, Stephan
    Pott, Christian
    Zumhagen, Sven
    Radu, Razvan
    Scheld, Hans H.
    Haverkamp, Wilhelm
    Schulze-Bahr, Eric
    Eckardt, Lars
    EUROPACE, 2012, 14 (03): : 396 - 401
  • [47] Implantable cardioverter defibrillator therapy in paediatric patients for primary vs. secondary prevention
    Thuraiaiyah, Jani
    Philbert, Berit Thornvig
    Jensen, Annette Schophuus
    Xing, Lucas Yixi
    Joergensen, Troels Hoejsgaard
    Lim, Chee Woon
    Jakobsen, Frederikke Noerregaard
    Baekke, Pernille Steen
    Schmidt, Michael Rahbek
    Idorn, Lars
    Holdgaard Smerup, Morten
    Johansen, Jens Brock
    Riahi, Sam
    Nielsen, Jens Cosedis
    De Backer, Ole
    Sondergaard, Lars
    Jons, Christian
    EUROPACE, 2024, 26 (09):
  • [48] Implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: an updated systematic review and meta-analysis of outcomes and complications
    Wang, Nelson
    Xie, Ashleigh
    Tjahjono, Richard
    Tian, David H.
    Phan, Steven
    Yan, Tristan D.
    Bajona, Pietro
    Phan, Kevin
    ANNALS OF CARDIOTHORACIC SURGERY, 2017, 6 (04) : 298 - 306
  • [49] Implantable Cardioverter-Defibrillator therapy for primary prevention of sudden cardiac death in patients with severe Chagas cardiomyopathy
    Cardinalli-Neto, Augusto
    Nakazone, Marcelo A.
    Grassi, Luciano V.
    Tavares, Bruno G.
    Bestetti, Reinaldo B.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 150 (01) : 94 - 95
  • [50] The Implantable cardioverter-defibrillator and hypertrophic cardiomyopathy.: Experience at three centers
    Marin, Francisco
    Gimeno, Juan R.
    Paya, Eduardo
    Garcia-Alberola, Arcadio
    Perez-Alvarez, Luisa
    Fernandez, Xusto
    de la Morena, Gonzalo
    Sogorb, Francisco
    Castro-Beiras, Alfonso
    Valdes, Mariano
    Martinez, Juan G.
    Monserrat, Lorenzo
    REVISTA ESPANOLA DE CARDIOLOGIA, 2006, 59 (06): : 537 - 544